The chief executive of vitamins group Blackmores has undone one of the acquisitions made by former boss Christine Holgate after four years.
Alastair Symington will sell the Global Therapeutics business and its Fusion Health and Oriental Botanicals brands for $27 million to ASX-listed McPherson's because they are now deemed to be non-core.
Loading...
Simon Evans writes on business specialising in retail, manufacturing, beverages, mining and M&A. He is based in Adelaide. Connect with Simon on Twitter. Email Simon at simon.evans@afr.com
